Alpheus Medical, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma (NCT07225621) | Alpheus Medical, Inc. | 2026-01-28 |
| Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma (NCT05362409) | Alpheus Medical, Inc. | 2022-06-29 |
Track Alpheus Medical, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.